What is the optimal method to convert a patient on a fentanyl 37.5 µg/hour transdermal patch replaced every three days to an oral opioid regimen?

Converting Fentanyl 37.5 µg/hour Transdermal Patch to Oral Opioids

Remove the fentanyl patch and immediately initiate oral morphine at 60 mg daily (divided into 20 mg every 8 hours or 30 mg every 12 hours if using extended-release), with immediate-release morphine 10-15 mg available every 2-4 hours for breakthrough pain. 1

Conversion Calculation

The fentanyl 37.5 µg/hour patch delivers approximately 900 µg over 24 hours. Using the FDA-approved conversion ratio:

• Fentanyl 37.5 µg/hour corresponds to approximately 60-134 mg oral morphine daily 1
• Start conservatively at 60 mg oral morphine daily to avoid overdosing, as the FDA explicitly warns that conversion tables from fentanyl to other opioids are conservative and can overestimate the new opioid dose 1

Timing of Transition

Critical timing consideration: The FDA labeling explicitly states that conversion tables "cannot be used to convert from fentanyl transdermal system to another opioid because these conversions will result in an overestimation of the dose of the new opioid" and "may result in fatal overdosage" 1. Therefore:

• Remove the patch at the scheduled change time
• Start oral morphine immediately upon patch removal (do not wait 12-24 hours as with some protocols)
• The subcutaneous fentanyl reservoir will continue releasing drug for 12-24 hours after patch removal, providing a natural "bridge" 2

Dosing Regimen Options

Option 1 (Preferred for most patients):

• Oral morphine extended-release 30 mg every 12 hours
• Immediate-release morphine 10 mg every 2-4 hours as needed for breakthrough pain
• This provides baseline coverage while the fentanyl depot depletes

Option 2 (For patients requiring more frequent dosing):

• Immediate-release morphine 20 mg every 8 hours
• Additional immediate-release morphine 10 mg every 2-4 hours for breakthrough pain

Monitoring and Titration

First 24-48 hours are critical:

• Monitor closely for oversedation or respiratory depression during hours 0-24 (overlapping fentanyl from depot + new oral morphine)
• Track breakthrough medication use
• Assess pain scores every 4-6 hours
• After 48 hours, adjust the total daily morphine dose based on baseline requirements plus breakthrough use

Dose adjustment formula:

• New daily dose = Current scheduled dose + (total breakthrough doses used in 24 hours × 0.5-1.0)
• Redistribute this total into scheduled doses
• Reassess every 2-3 days until stable 3

Alternative Oral Opioids

If morphine is contraindicated or poorly tolerated:

Oxycodone: 40 mg daily (using 1:1.5 morphine:oxycodone ratio) 4

• Start with 20 mg every 12 hours extended-release
• Immediate-release oxycodone 5-10 mg for breakthrough

Hydromorphone: 8-12 mg daily (using 1:5 to 1:7.5 morphine:hydromorphone ratio) 3, 4

• Start with 4 mg every 12 hours extended-release
• Immediate-release hydromorphone 2 mg for breakthrough

Critical Safety Warnings

• Never use the conversion tables in reverse (fentanyl to oral) at face value—they systematically overestimate and risk fatal overdose 1
• Ensure naloxone availability during the transition period 1
• Patients with renal impairment should preferentially receive oxycodone or hydromorphone over morphine due to accumulation of morphine-6-glucuronide 3
• The fentanyl depot effect means patients have overlapping opioid exposure for 12-24 hours—this is protective against withdrawal but increases overdose risk if oral doses are too high 2, 5

Common Pitfalls to Avoid

1. Waiting too long to start oral opioids: Start immediately upon patch removal; the depot provides natural bridging
2. Using conversion ratios bidirectionally: FDA tables are unidirectional (TO fentanyl only, not FROM fentanyl)
3. Inadequate breakthrough medication: Always provide immediate-release opioid at 10-15% of total daily dose for breakthrough 3
4. Premature dose escalation: Wait at least 48 hours before adjusting, allowing fentanyl depot to clear